Huge upside potential ahead in the 2nd half of 2013.. Load up
Top-line data later this year will make ZLCS soar... load up ladies and gents..
Oral form of Z160 taken BID is on par with prialt, neurontin and morphine... yet no side effects of dizziness, somnolence and neuropsychiatric issues...
If ZLCS can show efficacy in reducing lumbosacral radiculopathy pain, postherpetic neuralgia, diabetic peripheral neuropathy and fibromyalgia with Z160, the upside potential will be astronomical for this small biotech..
haha! love that movie! I am in the island mood.. the Cove effect. Don't worry, Be happy.. we got cash, we got girls... Don't worry, Be happy.. Looks like ZLCS got some fresh Bahamian conch salad over the lunch break and it is ready to soar again! here we go! Cheers!